{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-038478","form_type":"8-K","ticker":"UTHR","cik":"0001082554","company_name":"UNITED THERAPEUTICS Corp","filed_at":"2024-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.312224+00:00","generated_at":"2026-06-04T08:19:51.744226+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"United Therapeutics authorizes $1B accelerated share repurchase with Citibank","bullets":["Board authorized up to $1B of common stock repurchase; ASR agreement signed with Citibank.","Initial delivery of ~3,275,199 shares (80% of estimated total) on March 27, 2024.","Final settlement to occur in Q2 ($300M) and Q3 2024 ($700M) based on VWAP.","Company also plans $400M credit facility paydown in 2024; $100M already paid in Q1.","CEO cites balance sheet strength and confidence in near-term prospects for buyback."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-038478","json":"https://secwatch.observer/filing/0001104659-24-038478.json","markdown":"https://secwatch.observer/filing/0001104659-24-038478.md","text":"https://secwatch.observer/filing/0001104659-24-038478.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1082554/000110465924038478/0001104659-24-038478-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/000110465924038478/tm249556d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T08:19:51.744226+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"38465ce15b837258a0a9370c51abbb0fcf536272","claim":"UNITED THERAPEUTICS Corp entered into ASR Agreement with Citibank, N.A. valued at $1.0 billion (effective 2024-03-25).","evidence_excerpt":"On March 25, 2024, the Company entered into an accelerated share repurchase agreement (the ASR Agreement ) with Citibank, N.A. ( Citi ) to repurchase approximately $1 billion of the Company’s common stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1082554/000110465924038478/0001104659-24-038478-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Citibank, N.A."},{"label":"Value","value":"$1.0 billion"},{"label":"Effective","value":"2024-03-25"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}